A pooled analysis investigated the prognostic role of DNA mismatch repair status in patients with stage III colon cancer treated with a standard adjuvant chemotherapy regimen.
The pharmacy benefits manager Express Scripts has signaled its embrace of value-based care with its announced purchase of eviCore.
Researchers compared a combination regimen with the current standard of care for first-line treatment of advanced soft-tissue sarcoma.
Patients with metastatic cancer who are treated with an anti-programmed death therapy are at an increased risk for neurological complications.
The US Food and Drug Administration has granted breakthrough therapy designation to an EGFR tyrosine kinase inhibitor for the first-line treatment of EGFR-positive non-small cell lung cancer.
In a new study, researchers investigated the likelihood of therapy adherence in patients with chronic myeloid leukemia with heavily subsidized Medicare part D plans, compared with those without a subsidy.
A recent study reports that the cross-sectional location of gastric cancer is associated with long-term survival outcomes of patients as tumor invasion deepens.
The American Society of Clinical Oncology and Friends of Cancer Research recently released a joint recommendation to promote inclusiveness for cancer clinical trial enrollment criteria.
Approximately 66% of patients with medullary thyroid carcinoma do not receive a complete thyroidectomy or central neck lymph-node dissection, despite recommendations in the American Thyroid Guidelines suggesting combining the two procedures.
A recent phase III trial demonstrated that initial therapy with an immuno-agent improves PFS in patients with HR+, HER2- breast cancer.